https://www.selleckchem.com/pr....oducts/sacituzumab-g
The primary outcome was in-hospital mortality. The secondary outcome was infectious complications (pneumonia, urinary tract infection, surgical site infection, and sepsis). Propensity score matching created 665 pairs of patients who received quetiapine or risperidone. The primary outcome was observed in 19 (2.9%) of the quetiapine group and 11 (1.7%) of the risperidone group (relative risk, 1.27; 95% confidence interval, 0.97-1.68; P = .14). #link# The secondary outcome did not differ significantly between the groups. In t
Curtir
Comentario
Compartilhar
